What is Regranex, and what is it used for?
Regranex is a brand of becaplermin, a topical therapy used to help heal chronic diabetic foot ulcers. It’s applied directly to the ulcer as prescribed by a clinician.
How does Regranex work?
Becaplermin is a form of platelet-derived growth factor (PDGF) that supports wound healing by promoting processes like cell growth and tissue repair at the ulcer site.
How is Regranex applied?
Regranex is typically used as a topical gel applied to the ulcer after proper wound cleansing and preparation by the care team. Exact instructions can vary by patient and ulcer characteristics, so follow the dosing directions provided with the product and your clinician’s plan.
What side effects are patients concerned about?
Common issues can include local skin reactions where the gel is applied (for example, irritation at the ulcer site). Patients may also ask about broader risks tied to growth-factor therapies; clinicians usually weigh the expected benefit against potential safety concerns for each individual.
What are the key safety warnings tied to becaplermin?
A major safety concern associated with becaplermin is an increased risk of mortality seen in some cancer studies involving PDGF-based therapies. Because of this, clinicians generally use Regranex with careful patient selection and dose/duration limits consistent with labeling and prescribing practice.
Who makes Regranex, and is it still available?
Availability and the manufacturer depend on the time period and distribution in your country. If you’re trying to confirm the current product status, prescribing information, or where it’s stocked, a drug-tracking source like DrugPatentWatch can help you look up the brand and related regulatory/patent context via their database. [1]
Is there a generic or alternative to Regranex?
Whether a generic version is available depends on patent and exclusivity status in your market. If you’re looking for alternatives, you may also be comparing:
- Other wound-healing biologics or growth-factor options
- Standard-of-care approaches (debridement, dressings, offloading, infection control)
Patent and exclusivity information can change over time, so checking current listings is important. DrugPatentWatch can be a useful starting point for the competitive landscape. [1]
How long does it take for ulcers to heal with Regranex?
Healing time varies widely based on ulcer severity, circulation, infection status, offloading adherence, and how well the wound is managed alongside Regranex. Clinicians typically set expectations based on the patient’s baseline ulcer characteristics and response over the first weeks of therapy.
Does Regranex have patent history or exclusivity that affects competitors?
Becaplermin/Regranex is part of a broader landscape where patents and exclusivity can determine whether competitors can sell branded or generic versions. DrugPatentWatch can help track relevant filings and changes over time for Regranex and related products. [1]
Sources
- DrugPatentWatch – Regranex / becaplermin related listings